Literature DB >> 31873809

Primary care providers' awareness, knowledge, and practice with regard to cardiovascular risk in patients with rheumatoid arthritis : PCPs' awareness, knowledge, and practice with regard to CV risks in patients with RA.

Stella Pak1.   

Abstract

Rheumatoid arthritis (RA) is a systemic auto-inflammatory disease associated with increased cardiovascular risk. Early identification and aggressive cardiovascular risk factor modification are critical for improvement in morbidity and mortality in patients with RA. This study is a cross-sectional survey with the purpose of evaluating primary care providers' awareness, practice patterns, and satisfaction with continuing medical education on cardiovascular risk in patients with RA. Our study showed that 71% of clinicians felt that the CME on RA patient management regarding CV risk factors is inadequate. Only 37% of providers reported feeling well prepared to manage CV risk for RA patients. Only 15% of participants were actively initiating a discussion regarding CV risk with RA patients. A better understanding of the educational needs and practice patterns of primary care providers may warrant the development of strategies for cardiovascular risk management in patients with RA.

Entities:  

Keywords:  Cardiovascular disease; Continuing medical education; Primary prevention; Rheumatoid arthritis

Mesh:

Year:  2019        PMID: 31873809     DOI: 10.1007/s10067-019-04901-x

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  17 in total

1.  Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2005-06-11

Review 2.  Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity.

Authors:  Henry R Kramer; Jon T Giles
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-04       Impact factor: 4.794

3.  Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis.

Authors:  Inmaculada del Rincón; Joseph F Polak; Daniel H O'Leary; Daniel F Battafarano; John M Erikson; Jose F Restrepo; Emily Molina; Agustín Escalante
Journal:  Ann Rheum Dis       Date:  2014-05-20       Impact factor: 19.103

Review 4.  Cardiovascular education for people with rheumatoid arthritis: what can existing patient education programmes teach us?

Authors:  Holly John; Douglas Carroll; George D Kitas
Journal:  Rheumatology (Oxford)       Date:  2011-07-09       Impact factor: 7.580

5.  Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study.

Authors:  Mary A De Vera; Hyon Choi; Michal Abrahamowicz; Jacek Kopec; Maria Victoria Goycochea-Robles; Diane Lacaille
Journal:  Ann Rheum Dis       Date:  2011-03-06       Impact factor: 19.103

6.  Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  Maureen McMahon; Jennifer Grossman; John FitzGerald; Erika Dahlin-Lee; Daniel J Wallace; Bernard Y Thong; Humeira Badsha; Kenneth Kalunian; Christina Charles; Mohamad Navab; Alan M Fogelman; Bevra H Hahn
Journal:  Arthritis Rheum       Date:  2006-08

Review 7.  EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.

Authors:  R Agca; S C Heslinga; S Rollefstad; M Heslinga; I B McInnes; M J L Peters; T K Kvien; M Dougados; H Radner; F Atzeni; J Primdahl; A Södergren; S Wallberg Jonsson; J van Rompay; C Zabalan; T R Pedersen; L Jacobsson; K de Vlam; M A Gonzalez-Gay; A G Semb; G D Kitas; Y M Smulders; Z Szekanecz; N Sattar; D P M Symmons; M T Nurmohamed
Journal:  Ann Rheum Dis       Date:  2016-10-03       Impact factor: 19.103

8.  Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies.

Authors:  J Antonio Aviña-Zubieta; Hyon K Choi; Mohsen Sadatsafavi; Mahyar Etminan; John M Esdaile; Diane Lacaille
Journal:  Arthritis Rheum       Date:  2008-12-15

9.  Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis.

Authors:  S Van Doornum; G McColl; I P Wicks
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

10.  Aspirin use in rheumatoid arthritis patients with increased risk of cardiovascular disease.

Authors:  Jonida K Cote; Androniki Bili
Journal:  ISRN Rheumatol       Date:  2013-11-06
View more
  2 in total

1.  Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis.

Authors:  Avi Aronov; Yoo Jin Kim; Nadera J Sweiss; Noreen T Nazir
Journal:  Am J Prev Cardiol       Date:  2022-09-14

2.  Joint Destruction Is Associated With All Types of Cardiovascular Events in French Rheumatoid Patients: A Real-Life Study With Very Long Follow-Up.

Authors:  Marie Robert; Arnaud Hot; François Mifsud; Ndiémé Ndongo-Thiam; Pierre Miossec
Journal:  Front Med (Lausanne)       Date:  2020-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.